Posts
At a recent meeting of the San Francisco
AIDS Foundation that took place at the San Francisco Department of Public
Health, Oscar Bacon led a discussion about a new AIDS prevention pill. Bacon is
the lead clinician for the San Francisco Clinic that is now seeking volunteers
for the first demonstration trial of Truvada, produced by Gilead Sciences, Inc.
Truvada is the first pill ever to
block HIV before it strikes. Enrollment was opened on September 21 for 300
potential volunteers in the study. The study will examine how the drug will be
received by people who are, so far, uninfected, but are at high risk.
Recruiters are seeking study volunteers including transgender females and men
who have sex with men (MSM). Participants will receive 48 weeks of the drug at
no cost, in exchange for regular monitoring of their social habits and tests
that will assess the pill’s effectiveness in preventing transmission of the
virus.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!
